Nachrichten zur Amgen Inc. Aktie

Take the Zacks Approach to Beat the Markets: Bloom Energy, Microsoft & Amgen in Focus

Microsoft, Bloom Energy and Amgen highlight Zacks latest market moves, with strong gains across Focus List, recommendation and dividend portfolios.…

Klumpenrisiko KI-Aktien? Cramer warnt vor zu viel NVIDIA & Co. - Worauf Anleger setzen sollten

Cramer warnt vor zu großer KI-Konzentration und rät zur StreuungEr nennt sieben Alternativen aus Luftfahrt, Fintech, Gesundheit und EnergieAmgen fiel…

Amgen (AMGN) Rises Higher Than Market: Key Facts

In the latest trading session, Amgen (AMGN) closed at $414.61, marking a +2.11% move from the previous day.…

Bet on These 5 Dividend Growth Stocks Amid Rising Treasury Yields

Rising Treasury yields are reshaping market preferences, putting dividend growth stocks like EnerSys and Amgen in focus for income and…

Morgan Stanley flags Amgens edge after heart-drug rival stumbles

A private meeting with Amgen management left Morgan Stanley with a very different read than the broader markets.…

Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing

In the most recent trading session, Amgen (AMGN) closed at $385.65, indicating a +1.55% shift from the previous trading day.…

Top Research Reports for AMD, Linde & Amgen

AMD, Linde and Amgen highlight AI demand, contracted growth and drug launches, while supply, margin and pipeline risks remain key…

Amgen (AMGN) Dips More Than Broader Market: What You Should Know

The latest trading day saw Amgen (AMGN) settling at $382.47, representing a -2.25% change from its previous close.…

Amgen Aktie: MariTide bleibt der große Unsicherheitsfaktor - BMO wird vorsichtiger

Toronto (www.aktiencheck.de) - Amgen-Aktienanalyse von BMO Capital Markets:Die Analysten von BMO Capital Markets senken das Rating für die Aktie von…

Amgen and AstraZeneca report positive lung cancer trial results

Amgen and AstraZeneca report positive lung cancer trial results…

Stocks making the biggest moves midday: Amgen, Qualcomm, Expedia, CoreWeave & more

Here are some of the companies making headlines in midday trading.…

Cholesterol drug setback casts doubt over multibillion-dollar race

Novartis’ failure raises the stakes for Amgen and Eli Lilly in the race to turn lower Lp(a) levels into fewer…

Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus

Zacks spotlights Oportun Financial, Uranium Royalty and Amgen, alongside standout gains from its key stock portfolios.…

Amgen Aktie: Am Wendepunkt - diese Studiendaten könnten alles verändern!

Bad Marienberg (www.aktiencheck.de) - Amgen Inc. (ISIN: US0311621009, WKN: 867900, Ticker-Symbol: AMG, NASDAQ-Symbol: AMGN) rückt mit Macht ins Rampenlicht der…

Why Amgen (AMGN) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly…

AstraZenecas asthma drug Tezspire meets all goals in late-stage esophagitis trial

AstraZeneca said on Thursday ?its asthma drug, Tezspire, developed with Amgen , ?met its main and secondary goals in a…

Opening Bell: Wall Street startet im Plus; Nvidia, Barrick, Coca-Cola, Amgen, Sea, Moderna, AirBnB, Target im Fokus

Nach einem von Vorsicht geprägten Handel zu Wochenbeginn zeichnen sich an den US-Aktienmärkten am Dienstag Gewinne ab. Rückenwind dürfte dabei…

Top Research Reports for Amgen, Thermo Fisher & Pepsi

Amgen, Thermo Fisher and PepsiCo headline todays research, with growth drivers, strategic moves and key risks in focus.…

Amgen Aktie: Jetzt wird es für Anleger brenzlig!

Bad Marienberg (www.aktiencheck.de) - Die Amgen-Aktie (ISIN: US0311621009, WKN: 867900, Ticker-Symbol: AMG, NASDAQ-Symbol: AMGN) steht vor einer spannenden Bewährungsprobe. Barclays…

Amgen Aktie: Repatha gewinnt an Dynamik - Analysten werden optimistischer

New York (www.aktiencheck.de) - Amgen-Aktienanalyse von Oppenheimer:Die Analysten von Oppenheimer stufen die Aktie von Amgen Inc. (ISIN: US0311621009, WKN: 867900,…

ROUNDUP: Amgen wird erneut etwas optimistischer - Anleger hoch erfreut

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat nach einem starken zweiten Quartal erneut die…

Amgen gains after strong quarterly results and continued product momentum

Amgen Inc (NASDAQ:AMGN, XETRA:AMG) shares rose about 4% on Wednesday after the biotechnology company reported second quarter 2026 results that…

Amgen wird erneut etwas optimistischer - Anleger unbeeindruckt

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat nach einem starken zweiten Quartal erneut die…

AMGN Beats on Q2 Earnings, Lifts Outlook Despite Legacy Drug Pressure

Amgen beats Q2 earnings and revenue estimates and lifts its 2026 outlook. Key products witness strong growth despite biosimilar pressure…

Amgen (AMGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter…

Amgen (AMGN) Q2 Earnings and Revenues Surpass Estimates

Amgen (AMGN) delivered earnings and revenue surprises of +12.32% and +6.52%, respectively, for the quarter ended June 2026. Do the…

Are These 5 Pharma Stocks Set to Surpass Q2 Earnings Forecasts?

Amgen, Pfizer, Eli Lilly, Merck and Novo Nordisk are set to report Q2 results this week after a strong start…

Amgen hit by cybersecurity incident, sensitive data stolen

…

Amgen discloses data breach, says patient information was stolen

Amgen discloses data breach, says patient information was stolen…

Amgen Q2 Earnings Preview: Will the Beat Streak Continue?

Amgen heads into Q2 earnings with a history of beats as investors watch key drug sales trends and seek updates…

Watch Out, Eli Lilly and Novo Nordisk: Amgens Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and Its Coming for Your Patients

Will this pharma company become a new leader in the weight loss market?…

dpa-AFX ProFeed